FIELD: biochemistry.
SUBSTANCE: invention relates to a bispecific diabody molecule specifically binding to an immune effector cell CD3 epitope and an epitope of an antigen expressed by an HIV-infected cell, as well as to a bispecific diabody molecule specifically binding to an immune cell effector cell epitope CD16 and an epitope of an antigen expressed by an HIV-infected cell. Also disclosed is a pharmaceutical composition containing said diabody. Invention also relates to use of said bispecific diabody molecule for treating latent, persistent and inactive HIV infection.
EFFECT: invention enables effective treatment of HIV infection.
24 cl, 7 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR USING CD32B x CD79B-BINDING MOLECULES IN TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | 2017 |
|
RU2772434C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| VARIANT CD3 BINDING DOMAINS AND THEIR USE IN COMBINATION THERAPY FOR TREATMENT OF DISEASES | 2019 |
|
RU2810222C2 |
| CD3-BINDING DOMAIN | 2015 |
|
RU2742691C2 |
| MULTIVALENT Fv-ANTIBODIES | 2016 |
|
RU2785766C2 |
| TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE | 2015 |
|
RU2753882C2 |
| NEW BISPECIFIC POLYPEPTIDE COMPLEXES AGAINST CD3/CD19 | 2018 |
|
RU2788127C2 |
| ANTIBODIES, SPECIFIC TO HYPERPHOSPHORYLATED TAU-PROTEIN, AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2727911C2 |
| ANTIBODIES CONTAINING ONLY HEAVY CHAINS THAT BIND TO CD22 | 2018 |
|
RU2797348C2 |
| CRYOPRESERVED CELLS ARE NATURAL KILLERS PRELOADED WITH ANTIBODY CONSTRUCTION | 2019 |
|
RU2819927C2 |
